Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3SBio (formerly Shenyang Sunshine Pharmaceutical) is a leading Chinese biotechnology company focused on the development, manufacturing, and commercialization of biopharmaceuticals. The company is a pioneer in the Chinese biologics market, best known for its flagship products EPIAO (recombinant human erythropoietin) and TPIAO (recombinant human thrombopoietin). 3SBio operates a fully integrated platform spanning R&D, GMP-certified manufacturing, and an extensive commercial infrastructure. Beyond its core erythropoiesis and oncology portfolio, the company has expanded into nephrology, dermatology, and autoimmune diseases through internal development and strategic acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S.S.S..